Verified email-pattern data for Draupnir Bio is currently limited. You can still use the company insights and contact sections below.
Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – 40% of the human proteome – untouched. At Draupnir, we are extending the potential of TPD to both extracellular and membrane-bound proteins in a pioneering approach using our novel and differentiated, proprietary technology platform which targets lysosome receptors and has the potential to revolutionise the field of TPD.
Led by a highly experienced team of pharma and biotech industry leaders, Draupnir is a spin-out from Aarhus University, Denmark and the Max-Planck Society, Germany and is backed by a syndicate of leading European investors.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Copenhagen, Dk
- Industry
- Biotechnology Research
- Website
- https://draupnir.bio/
- Keywords
- biotechnology, biotech, targeted protein degradation, membrane-bound proteins, extracellular targets, lysosome.
- HQ
- Copenhagen
Draupnir Bio Questions
Draupnir Bio's website is https://draupnir.bio/
Draupnir Bio's LinkedIn profile is https://dk.linkedin.com/company/draupnirbio
Draupnir Bio has
16 employees.
View email and phone details for 16
employees at Draupnir Bio.
Draupnir Bio's industry is
Biotechnology Research
Draupnir Bio's top competitors are
Muna Therapeutics,
Expressionedits,
Relation,
Infinitopes,
Bioptimus,
Commit Biologics,
Quotient Therapeutics,
Artica Therapeutics,
Teitur Trophics,
Adcytherix.
Draupnir Bio's categories are Biotechnology Research
Draupnir Bio's founding year is 2017
Explore related pages
Related company profiles:
Top Draupnir Bio Employees
-
Casper Tind Hansen
n/a
Copenhagen, Capital Region Of Denmark, Denmark, Denmark2vip.cybercity.dk, novo.dk -
Rob Scott MD
Chief Medical Officer Abbvie (Retired)
Los Angeles Metropolitan Area, United States, United States4robscott.org, abbvie.com, redxpharma.com, abbvie.com1 (847) 9XXXXXXX
-
Emmanuelle Coutanceau
Partner At Novo Holdings
Copenhagen, Capital Region Of Denmark, Denmark, Denmark6yahoo.fr, novo.dk, omnescapital.com, ca-privateequity.fr, aurigapartners.com, novo.com -
Marianne Lundsgaard Kristensen
Lab Manager At Draupnir Bio
Central Denmark Region, Denmark, Denmark1au.dk
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.